"Wij zijn een behandelcentrum voor type 1 diabetes. Om een chronische en ingewikkelde ziekte als type 1 diabetes goed te behandelen is een 100% focus nodig van je behandelteam. Behandelaars die je het vertrouwen en de kennis geven om je dagelijks leven zo goed mogelijk te kunnen blijven leiden. Die altijd bereikbaar zijn, die kennis hebben van de nieuwste technologieën en die ook op afstand met je meekijken als je dat wilt. Diabeter is dat gespecialiseerde behandelcentrum voor type 1 diabetes. Wij zijn gevestigd in Rotterdam, Eindhoven, Schiphol, Groningen en Deventer."

During the past decade, Diabeter conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Diabeter" are "Diabetes Mellitus" (2 trials), "Autoimmune Diabetes" (1 trials), "Autoimmune Diseases" (1 trials), "Diabetes" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Diabeter" in a lesser frequency.

Most popular intervention types in "Diabeter" are "Biological" (1 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Colecalciferol 2000 IU" (1 trials), "InPen with Guardian 4 System" (1 trials), "Placebo" (1 trials), "Placebo for recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®" (1 trials) and "Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabeter" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Diabeter". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Diabeter, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Diabeter, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Diabeter has several departments that took part in Clinical trials: "Diabeter" - 2 trials